Wednesday, July 8, 2026

pharma · Bladder (Urothelial, Transitional Cell) Cancer · Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) · RLMD

RELMADA THERAPEUTICS

News and analysis for RELMADA THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

Coral Gables, USA HQ
2004 Founded
33 Employees
Public company Type
RLMD · NYSE Ticker
Company details
Status
Public
HQ
Coral Gables, USA
Founded
2004
Employees
33
Programs
6
Drugs
5
Patents
7
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning RELMADA THERAPEUTICS — regulatory, clinical, and market coverage.

News and analysis for RELMADA THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning RELMADA THERAPEUTICS yet.

Back to company overview →